Josephine Torrente's most recent trade in Agile Therapeutics Inc was a trade of 1,065 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 8, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Agile Therapeutics Inc | Josephine Torrente | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 1,065 | 1,065 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Josephine Torrente | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 935 | 988 (0%) | 0% | 0 | Common Stock | |
| Agile Therapeutics Inc | Josephine Torrente | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 807 | 807 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Josephine Torrente | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 670 | 2,659 (0%) | 0% | 0 | Common Stock | |
| Agile Therapeutics Inc | Josephine Torrente | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2021 | 97,116 | 97,116 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Josephine Torrente | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2021 | 79,593 | 79,593 (0%) | 0% | 0 | Common Stock |